Webinars


13th October, 2017

Linking Evidence and Value Strategies with the Right Stakeholder

22nd September, 2017

Outcomes-Based Agreements and Innovative Contracting for Biopharmaceuticals

7th June, 2017

Using Early Economic Models in Developing your Evidence Strategy

9th May, 2017

Optimise Medical Publishing and Avoid “Predatory Journals”

1st May, 2017

Technology Solutions for Late Phase Research: Optimising Real World Data Assets

26th April, 2017

Addressing the challenges of Type II Diabetes global clinical trials via use of high quality laboratory solutions

5th April, 2017

Optimise Your Regulatory & HTA Submissions with a Comprehensive Health Economic & Epidemiologic Evidence Strategy

16th November, 2016

Development and Validation of Clinician-Reported Outcomes Measures (ClinROs)

2nd November, 2016

Leveraging smartphone sensors to measure novel health outcomes

26th October, 2016

Bring Your Own Device (BYOD) eCOA – Instrument Validation Methodology

25th October, 2016

Meeting Evidentiary Needs with Electronic Health Records: Transformative Applications in Observational Studies and Pragmatic Clinical Trials

14th October, 2016

Market Access Hurdles for Cell and Gene Therapies: Managing Evidence to Enhance Market Adoption

21st September, 2016

Validating Select Physical Performance Outcome (PerfO) Assessments to Support Labelling Claims in the US: Methods and Lessons Learned

7th September, 2016

From Big Data to Patient Engagement in Clinical Trials

26th July, 2016

Linguistic Validation – When Google Translate Just Isn’t Enough

6th July, 2016

Activity Monitoring, Setting Standards for Clinical Research

30th June, 2016

Learn about Laboratory Considerations when Developing Multiple Myeloma Trials

22nd June, 2016

Developing an Observer-Reported Outcomes Measure (ObsRO): Best Practices, Challenges, and Solutions

18th May, 2016

Overview of the Regulation Landscape for Digital Health

21st January, 2016

Pistoia Alliance Debates: Clinical trials and wearables

8th December, 2015

FDA Waivers for TQT Studies: How Early Precision QT™ for Cardiac Safety Testing Can Elevate Drug Development and Lower Study Costs

18th November, 2015

Global Regulatory Affairs, Medical Devices: Your Partner in Medical Device Development

3rd November, 2015

Linguistic Validation of Clinical Outcomes Assessments (COAs) and Electronic Clinical Outcomes Assessments (eCOAs)